Arterra Bioscience Operating Cash Flow for the year ending December 31, 2024: USD 1.10 M

Arterra Bioscience Operating Cash Flow is USD 1.10 M for the year ending December 31, 2024, a -2.69% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Arterra Bioscience Operating Cash Flow for the year ending December 31, 2023 was USD 1.13 M, a -24.16% change year over year.
  • Arterra Bioscience Operating Cash Flow for the year ending December 31, 2022 was USD 1.49 M, a -6.11% change year over year.
  • Arterra Bioscience Operating Cash Flow for the year ending December 31, 2021 was USD 1.59 M, a 171.27% change year over year.
  • Arterra Bioscience Operating Cash Flow for the year ending December 31, 2020 was USD 586.21 K, a -69.89% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities